Skip to content

Study to check hair removing capacity of depilator tablet containing Calcium thioglycolate

To evaluate the safety and efficacy of hair remover tablet with calcium thioglycolate through open label randomized study for the removal of hair in volunteer - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069610
Enrollment
24
Registered
2024-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hair depilator tablet with active ingredient calcium Thioglycollate: Hair remover tablet is crushed and made into a paste using 0.5ml of water and then applied to 1 square inch of area

Sponsors

KOP Research Centre Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female and male subjects with unwanted hair on arms and legs 2. Subjects aged between 18- 50 years of age 3. Subjects who are willing to sign informed concerned form. 4.Subjects consenting for photograph

Exclusion criteria

Exclusion criteria: 1.Subjects who doesn’t have hair or very scarce hair over arms and legs 2.Subjects below 18 years of age 3.Subjects who refuse to sign informed consent form 4.Pregnant and feeding women 5.Subjects who have wound at the application sites 6.Subjects with known allergy to any ingredient 7.Subjects with tattoo mark at area of application 8.Subjects under any medication.

Design outcomes

Primary

MeasureTime frame
To evaluate safety and efficacy of hair remover tablet with Kopcolate in depilating hair after application for duration of 5, 7 and 10 minutes. Parametes for assessment of IP efficacy are 1. Easy of application of product 2. Skin softness after hair removal 3. Satisfaction with the amount of hair removal. 4. odour of the product 5. Ease of removal after application All parameters assessed on scale of 0 to 5 where 0 is not good and 5 is excellent.Timepoint: To evaluate safety and efficacy of hair remover tablet with Kopcolate in depilating hair after application for duration of 5 minutes, 7 minutes and 10 minutes. There is no repeat application and there is recall or follow-up visits. Total duration is 30 minutes only.

Secondary

MeasureTime frame
To evaluate safety of IP for duration of 10 minutes of application. Derma safety for skin rashes, allergy or irritation will be evaluated.Timepoint: 5 minutes 7 minutes & 10 minutes total of 30 minutes only. No repeat follow-up visit.

Countries

India

Contacts

Public ContactDr Lakshmipathy R N

Smartmed Research Pvt Ltd

drinvestigator@myyahoo.com09538207347

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026